Literature DB >> 11049730

Neuroanatomical localisation of Substance P in the CNS and sensory neurons.

A Ribeiro-da-Silva1, T Hökfelt.   

Abstract

The anatomical distribution of Substance P (SP) has been investigated since the development of antibodies against it in the 1970s. Although initial studies were performed with antibodies that also recognised the other endogenous neurokinins, most of the initial descriptions are surprisingly still valid today. In this review, we provide an integrated overview of the pathways containing SP in the central and peripheral nervous systems. The highest densities of SP immunoreactivity occur in the superficial dorsal horn of the spinal cord, in the substantia nigra and in the medial amygdaloid nucleus. In the peripheral nervous system, SP occurs in high concentrations in small diameter primary sensory fibres and in the enteric nervous system. SP is extensively co-localised with classical transmitters and other neuropeptides. In the spinal cord, SP immunoreactive axonal boutons are preferentially presynaptic to neurons expressing the SP receptor, suggesting that the neurokinin acts at a short distance from the release site. In contrast, in the periphery, the situation probably differs in the autonomic ganglia, where the targets are directly innervated by SP, and in other peripheral territories, where SP has to diffuse through the connective tissue to reach the structures expressing the receptor. Copyright 2000 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11049730     DOI: 10.1054/npep.2000.0834

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  45 in total

1.  Noradrenaline regulates substance P release from rat dorsal root ganglion neurons in vitro.

Authors:  Yan-Jie Wang; Xing-Fu Li; Feng Ding; Qiang Shu; Li-Jun Song; Xiao Yu; Hua-Xiang Liu
Journal:  Neurosci Bull       Date:  2011-10       Impact factor: 5.203

2.  Role of substance P in the regulation of glucose metabolism via insulin signaling-associated pathways.

Authors:  Iordanes Karagiannides; Kyriaki Bakirtzi; Efi Kokkotou; Dimitris Stavrakis; Kara Gross Margolis; Thomas Thomou; Nino Giorgadze; James L Kirkland; Charalabos Pothoulakis
Journal:  Endocrinology       Date:  2011-10-18       Impact factor: 4.736

3.  Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar rats.

Authors:  Lydia O Ayanwuyi; Serena Stopponi; Massimo Ubaldi; Andrea Cippitelli; Cinzia Nasuti; Ruslan Damadzic; Markus Heilig; Jesse Schank; Kejun Cheng; Kenner C Rice; Roberto Ciccocioppo
Journal:  Br J Pharmacol       Date:  2015-10-22       Impact factor: 8.739

4.  Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptors.

Authors:  P Malherbe; F Knoflach; M C Hernandez; T Hoffmann; P Schnider; R H Porter; J G Wettstein; T M Ballard; W Spooren; L Steward
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

5.  Regulatory effects of insulin-like growth factor-1 on the expression of sensory neuropeptide mRNAs in cultured dorsal root ganglion neurons with excitotoxicity induced by glutamate.

Authors:  Hui-Cui Gong; Xiang-Dong Yang; Zhen Liu; Zi-Ying Xing; Huai-Jing Wang; Zhen-Zhong Li
Journal:  Neurosci Bull       Date:  2010-04       Impact factor: 5.203

6.  Neurogenic exacerbation of microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi.

Authors:  Vinita S Chauhan; David G Sterka; David L Gray; Kenneth L Bost; Ian Marriott
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

7.  Effects of substance P in the amygdala, ventromedial hypothalamus, and periaqueductal gray on fear-potentiated startle.

Authors:  Zuowei Zhao; Yong Yang; David L Walker; Michael Davis
Journal:  Neuropsychopharmacology       Date:  2008-04-16       Impact factor: 7.853

8.  Sleep-inducing effect of substance P-cholera toxin A subunit in mice.

Authors:  Mark R Zielinski; Dmitry Gerashchenko
Journal:  Neurosci Lett       Date:  2017-09-01       Impact factor: 3.046

9.  Overlapping expression of serotonin transporters and neurokinin-1 receptors in posttraumatic stress disorder: a multi-tracer PET study.

Authors:  A Frick; F Åhs; Å M Palmquist; A Pissiota; U Wallenquist; M Fernandez; M Jonasson; L Appel; Ö Frans; M Lubberink; T Furmark; L von Knorring; M Fredrikson
Journal:  Mol Psychiatry       Date:  2015-12-01       Impact factor: 15.992

10.  Evaluation of the anxiolytic-like effect of NKP608, a NK1-receptor antagonist, in two rat strains that differ in anxiety-related behaviors.

Authors:  Leandro F Vendruscolo; Reinaldo N Takahashi; Gustavo R Brüske; André Ramos
Journal:  Psychopharmacology (Berl)       Date:  2003-08-12       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.